Ron Van Schaik

16PUBLICATIONS
136CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmacogenomicsCardiology (incl. cardiovascular diseases)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 08, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

|May 25, 2026
Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer.

|Apr 24, 2026
The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine.

|Feb 26, 2026
Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

W W A van den Broek, Jaouad Azzahhafi, Qiu Ying F van de Pol

|May 01, 2025
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study.

Niels Heersche, Daan A C Lanser, Esther Oomen-de Hoop

|Mar 14, 2025
Pharmacokinetics of betamethasone in pre-eclampsia: An in vivo and ex vivo study.

Sam Schoenmakers, Letao Li, Anna C M Kluivers

Pageof 3

Frequent Collaborators

6 joint publications

Ron H J Mathijssen

3 joint publications

Anne-Marie C Dingemans

3 joint publications

Jesse J Swen

3 joint publications

Niels Heersche